Chemours
About: The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
Employees: 6,200
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
100% more funds holding in top 10
Funds holding in top 10: 3 [Q2] → 6 (+3) [Q3]
34% more call options, than puts
Call options by funds: $39M | Put options by funds: $29.1M
9% more repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 114
0.78% more ownership
Funds ownership: 81.77% [Q2] → 82.55% (+0.78%) [Q3]
4% less funds holding
Funds holding: 434 [Q2] → 416 (-18) [Q3]
9% less capital invested
Capital invested by funds: $2.75B [Q2] → $2.5B (-$244M) [Q3]
18% less first-time investments, than exits
New positions opened: 62 | Existing positions closed: 76
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Mizuho John Roberts 41% 1-year accuracy 16 / 39 met price target | 17%upside $21 | Neutral Maintained | 7 Jan 2025 |
Goldman Sachs Duffy Fischer 62% 1-year accuracy 8 / 13 met price target | 17%upside $21 | Neutral Maintained | 7 Jan 2025 |
RBC Capital Arun Viswanathan 16% 1-year accuracy 11 / 70 met price target | 40%upside $25 | Outperform Reiterated | 12 Dec 2024 |
Barclays Michael Leithead 32% 1-year accuracy 6 / 19 met price target | 28%upside $23 | Equal-Weight Maintained | 5 Nov 2024 |
Morgan Stanley Vincent Andrews 25% 1-year accuracy 1 / 4 met price target | 40%upside $25 | Equal-Weight Maintained | 5 Nov 2024 |
Financial journalist opinion
Based on 6 articles about CC published over the past 30 days